Bioscience Today

Bioscience Today Bioscience Today is a contemporary publication with the goal of making the UK Life Sciences sector a focal point for clinical research and medical innovation.

Bioscience Today (previously Bioscience Journal) is a contemporary publication with the goal of making the UK Life Sciences sector a focal point for clinical research and medical innovation. Bioscience Today is available in both print and digital formats, and is aimed towards decision makers throughout the Bioscience, Medical, Pharmaceutical and Healthcare markets. With a global appeal, its content is independent and politically unbiased, and driven by investigative journalism and expert analysis from industry leaders. Covering key aspects within its chosen industries, Bioscience Today sheds light on industry-impacting stories and reveals the major players behind the growth of the UK’s Bioscience sector.

A team from UNIGE and the University of Pisa has designed surprisingly stable molecular assemblies, paving the way for n...
28/11/2025

A team from UNIGE and the University of Pisa has designed surprisingly stable molecular assemblies, paving the way for new drug constructs and geometrically controlled materials https://www.biosciencetoday.co.uk/a-new-architecture-at-the-heart-of-molecules/

A team from UNIGE and the University of Pisa has designed surprisingly stable molecular assemblies, paving the way for new drug constructs and geometrically controlled materials. Can you imagine a life-saving molecule whose “twin” is a deadly poison? As surprising as it may seem, this chemical r...

Scientists have unlocked new details on important ‘receptor’ proteins – promising targets for the creation of novel drug...
27/11/2025

Scientists have unlocked new details on important ‘receptor’ proteins – promising targets for the creation of novel drugs for metabolic conditions ranging from diabetes to obesity and inflammatory disorders https://www.biosciencetoday.co.uk/new-discovery-in-diabetes-and-obesity-treatment/

Scientists have unlocked new details on important ‘receptor’ proteins –promising targets for the creation of novel drugs for metabolic conditions ranging from diabetes to obesity and inflammatory disorders. The discovery – published in Nature and led by the University of Glasgow, Queens Univ...

New data reveals a 57% drop in costs when compared to Q1 (April to June) 2015/16 https://www.biosciencetoday.co.uk/signi...
26/11/2025

New data reveals a 57% drop in costs when compared to Q1 (April to June) 2015/16 https://www.biosciencetoday.co.uk/significant-decline-in-cost-of-dependency-forming-medicines-prescribed-in-england/

New data reveals a 57% drop in costs when compared to Q1 (April to June) 2015/16. Recently published NHS Business Services Authority (NHSBSA) data shows a significant reduction in the cost of dependency-forming medicines prescribed in the community, falling by 57% from Q1 (April to June) 2015/16 to....

Dekel Faruhi, VP of Product Adoption at Proofig AI, examines the pressures that U.S. institutions face in 2025, and how ...
25/11/2025

Dekel Faruhi, VP of Product Adoption at Proofig AI, examines the pressures that U.S. institutions face in 2025, and how research integrity is essential to academia’s very survival https://www.biosciencetoday.co.uk/research-integrity-under-stress/

Dekel Faruhi, VP of Product Adoption at Proofig AI, examines the pressures that U.S. institutions face in 2025, and how research integrity is essential to academia’s very survival. American academia is facing an incredible amount of political and financial pressure. Following President Donald Trum...

A breakthrough partnership could make personalised, life-saving cancer treatments affordable and widely available https:...
24/11/2025

A breakthrough partnership could make personalised, life-saving cancer treatments affordable and widely available https://www.biosciencetoday.co.uk/robotics-transforming-cell-therapy/

A breakthrough partnership could make personalised, life-saving cancer treatments affordable and widely available. A new robotic biomanufacturing cluster achieves a 74% cost reduction for life-saving cell therapies, according to developer Multiply Labs. The breakthrough, published in peer-reviewed s...

Gentle and rapid detachment of even delicate adherent cells https://www.biosciencetoday.co.uk/gentle-and-rapid-detachmen...
24/11/2025

Gentle and rapid detachment of even delicate adherent cells https://www.biosciencetoday.co.uk/gentle-and-rapid-detachment-of-even-delicate-adherent-cells/

Detachin™ Cell Detachment Solution from Amsbio provides a superior alternative to Trypsin/EDTA for gentle detachment of adherent cells from in vitro growth vessels. Widely cited in recent published papers1, 2, 3, 4 – Detachin™ is proven to quickly deliver gentle detachment of a wide variety of...

McGill researchers develop safe, scalable vibration technique to improve lab-grown tissues https://www.biosciencetoday.c...
23/11/2025

McGill researchers develop safe, scalable vibration technique to improve lab-grown tissues https://www.biosciencetoday.co.uk/good-vibrations-improve-lab-grown-tissues/

McGill researchers develop safe, scalable vibration technique to improve lab-grown tissues. Researchers in McGill’s Department of Mechanical Engineering have discovered a safe and low-cost method of engineering living materials such as tissues, organs and blood clots. By simply vibrating these mat...

Mark Withers, senior purchasing technician at King’s College London, explores how laboratories can adapt to lab space sh...
22/11/2025

Mark Withers, senior purchasing technician at King’s College London, explores how laboratories can adapt to lab space shortages https://www.biosciencetoday.co.uk/lab-advances-its-a-tight-fit/

Mark Withers, senior purchasing technician at King’s College London, explores how laboratories can adapt to lab space shortages. The UK’s science sector faces a critical lab space shortage. This is especially true in the golden triangle region including London, Oxford and Cambridge. There are 6....

Insmed recently opened a new R&D facility in Cambridge focused on synthetic rescue for serious diseases. Dr Tom Heightma...
21/11/2025

Insmed recently opened a new R&D facility in Cambridge focused on synthetic rescue for serious diseases. Dr Tom Heightman, SVP of Research at the global biopharmaceutical, explains why the company is focused on UK expansion https://www.biosciencetoday.co.uk/serious-disease-research-takes-big-step-forward-in-uk/

Insmed recently opened a new R&D facility in Cambridge focused on synthetic rescue for serious diseases. Dr Tom Heightman, SVP of Research at the global biopharmaceutical, explains why the company is focused on UK expansion. Insmed specialises in striving to deliver innovative therapies to transform...

An international study involving researchers from Durham University reveals that climate change is accelerating the rate...
20/11/2025

An international study involving researchers from Durham University reveals that climate change is accelerating the rate of development and global abundances of antibiotic resistance bacteria in soils https://www.biosciencetoday.co.uk/global-warming-accelerates-antibiotic-resistance-in-soils/

An international study involving researchers from Durham University reveals that climate change is accelerating the rate of development and global abundances of antibiotic resistance bacteria in soils. The findings, published in the journal Nature Ecology & Evolution, highlight a new and deeply conc...

Efficient extraction of proteins from bacterial cells. https://www.biosciencetoday.co.uk/efficient-extraction-of-protein...
20/11/2025

Efficient extraction of proteins from bacterial cells. https://www.biosciencetoday.co.uk/efficient-extraction-of-proteins-from-bacterial-cells/

SoluLyse™ from Amsbio is a bacterial protein extraction reagent that provides a highly efficient yet gentle method for extracting soluble proteins from bacterial cells. Based upon a proprietary non-ionic detergent formulation, with the SoluLyse™ reagent there is no need for time-consuming and cu...

Dr Anton Yuryev, consulting director, Bioinformatics and Data Science, Elsevier, explores two case studies where researc...
19/11/2025

Dr Anton Yuryev, consulting director, Bioinformatics and Data Science, Elsevier, explores two case studies where researchers have used AI to find drugs that can be repurposed for rare conditions https://www.biosciencetoday.co.uk/how-ai-is-driving-repurposing-of-drugs-for-rare-diseases/

Dr Anton Yuryev, consulting director, Bioinformatics and Data Science, Elsevier, explores two case studies where researchers have used AI to find drugs that can be repurposed for rare conditions. There are more than 300 million people worldwide living with a rare condition, but only 5% of 8,000 know...

Address

Tru Knit House
Newcastle Upon Tyne
NE16UF

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Bioscience Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Bioscience Today:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category